These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9528193)

  • 1. [Presence of HLA-DRB1 alleles in a group of patients with rheumatoid arthritis treated with low doses of sodium aurothiomalate].
    Bianucci G; Rombolà G; Tringali M; Curradi C; Bongi SM
    Clin Ter; 1997 Dec; 148(12):577-92. PubMed ID: 9528193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of low doses of sodium aurothiomalate in the treatment of rheumatoid arthritis. Current trends in basic therapy].
    Bianucci G; Maddali Bongi S; Cencetti A; Curradi C
    Clin Ter; 1996 Dec; 147(12):609-20. PubMed ID: 9296920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis.
    Toussirot E; Auge B; Tiberghien P; Chabod J; Cedoz JP; Wendling D
    J Rheumatol; 1999 Jul; 26(7):1446-51. PubMed ID: 10405928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
    González-Gay MA; Hajeer AH; García-Porrúa C; Dababneh A; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2002 Feb; 29(2):271-5. PubMed ID: 11842822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF).
    Barrera P; Balsa A; Alves H; Westhovens R; Maenaut K; Cornélis F; Fritz P; Bardin T; Ceu Maia M; Lopes-Vaz A; Pascual Salcedo D; de la Concha E; Radstake T; van de Putte LB; Migliorini P; Prudhomme JF; Charron D; Spyropoulou M; Mendes A; Spaepen M; Martinez M; Stavropoulos C;
    J Rheumatol; 2001 May; 28(5):968-74. PubMed ID: 11361224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of (Q)R/KRAA positive HLA-DRB1 alleles with disease progression in early active and severe rheumatoid arthritis.
    Seidl C; Koch U; Buhleier T; Möller B; Wigand R; Markert E; Koller-Wagner G; Seifried E; Kaltwasser JP
    J Rheumatol; 1999 Apr; 26(4):773-6. PubMed ID: 10229395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis.
    Saruhan-Direskeneli G; Inanc M; Fresko I; Akkoc N; Dalkilic E; Erken E; Karaaslan Y; Kinikli G; Oksel F; Pay S; Yucel E; Yentür SP; Duymaz-Tozkir J; Yilmaz V; Inanc N; Yazici H; Konice M; Direskeneli H
    Rheumatology (Oxford); 2007 Dec; 46(12):1842-4. PubMed ID: 18032542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of DRB1*01 and DRB1*04 alleles in a group of patients with rheumatoid arthritis living in Liguria.
    Rovetta G; Monteforte P; Buffrini L; Grignolo MC; Strada P; Garbarino L
    Int J Clin Pharmacol Res; 2005; 25(3):95-9. PubMed ID: 16366416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
    Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
    J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
    Kapitány A; Zilahi E; Szántó S; Szücs G; Szabó Z; Végvári A; Rass P; Sipka S; Szegedi G; Szekanecz Z
    Ann N Y Acad Sci; 2005 Jun; 1051():263-70. PubMed ID: 16126967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort.
    Wu H; Khanna D; Park G; Gersuk V; Nepom GT; Wong WK; Paulus HE; Tsao BP
    Arthritis Rheum; 2004 Oct; 50(10):3093-103. PubMed ID: 15476205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninherited maternal antigens do not play a role in rheumatoid arthritis susceptibility in Europe. European Consortium on Rheumatoid Arthritis Families.
    Barrera P; Balsa A; Alves H; Westhovens R; Maenaut K; Cornélis F; Fritz P; Bardin T; de Almeida G; Lopes-Vaz A; Pascual Salcedo D; de la Concha EG; Radstake TR; van de Putte LB; Migliorini P; Prud'homme JF; Charron D; Spyropoulou M; Mendes A; Spaepen M; Martinez M; Lepage V; Stravopoulos C
    Arthritis Rheum; 2000 Apr; 43(4):758-64. PubMed ID: 10765920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility.
    du Montcel ST; Michou L; Petit-Teixeira E; Osorio J; Lemaire I; Lasbleiz S; Pierlot C; Quillet P; Bardin T; Prum B; Cornelis F; Clerget-Darpoux F
    Arthritis Rheum; 2005 Apr; 52(4):1063-8. PubMed ID: 15818663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1 alleles associated with susceptibility or resistance to rheumatoid arthritis, articular deformities, and disability in Mexican Americans.
    del Rincón I; Escalante A
    Arthritis Rheum; 1999 Jul; 42(7):1329-38. PubMed ID: 10403259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
    Criswell LA; Lum RF; Turner KN; Woehl B; Zhu Y; Wang J; Tiwari HK; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges SL
    Arthritis Rheum; 2004 Sep; 50(9):2750-6. PubMed ID: 15457442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of HLA-DR alleles on rheumatoid arthritis: susceptibility and severity in Argentine patients.
    Citera G; Padulo LA; Fernandez G; Lazaro MA; Rosemffet MG; Maldonado Cocco JA
    J Rheumatol; 2001 Jul; 28(7):1486-91. PubMed ID: 11469451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.